Lymphocytes T CD8+ : Questions médicales fréquentes
Nom anglais: CD8-Positive T-Lymphocytes
Descriptor UI:D018414
Tree Number:A15.382.490.555.567.569.220
Termes MeSH sélectionnés :
Statistical Distributions
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphocytes T CD8+ : Questions médicales les plus fréquentes",
"headline": "Lymphocytes T CD8+ : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphocytes T CD8+ : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-18",
"dateModified": "2025-02-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphocytes T CD8+"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lymphocytes T",
"url": "https://questionsmedicales.fr/mesh/D013601",
"about": {
"@type": "MedicalCondition",
"name": "Lymphocytes T",
"code": {
"@type": "MedicalCode",
"code": "D013601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490.555.567.569"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphocytes T CD8+",
"alternateName": "CD8-Positive T-Lymphocytes",
"code": {
"@type": "MedicalCode",
"code": "D018414",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christoph Fraune",
"url": "https://questionsmedicales.fr/author/Christoph%20Fraune",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Tim Mandelkow",
"url": "https://questionsmedicales.fr/author/Tim%20Mandelkow",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Martina Kluth",
"url": "https://questionsmedicales.fr/author/Martina%20Kluth",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Claudia Hube-Magg",
"url": "https://questionsmedicales.fr/author/Claudia%20Hube-Magg",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Ronald Simon",
"url": "https://questionsmedicales.fr/author/Ronald%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. r.simon@uke.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A comprehensive quality evaluation strategy for ReDuNing injection by integrating UPLC-Orbitrap MS/MS profile and biological potency combined with multivariate statistical analysis.",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39151297",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpba.2024.116407"
}
},
{
"@type": "ScholarlyArticle",
"name": "Statistical analysis and environmental impact of pre-existing particle growth events in a Northern Chinese coastal megacity: A 725-day study in 2010-2018.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38750744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.scitotenv.2024.173227"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of the effect of the addition of an olive oil-derived antioxidant (Pectoliv-80A) in the extender for cryopreservation of rooster sperm through the use of a discriminant statistical tool.",
"datePublished": "2024-03-07",
"url": "https://questionsmedicales.fr/article/38513548",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psj.2024.103630"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysis.",
"datePublished": "2024-01-03",
"url": "https://questionsmedicales.fr/article/38172810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-023-02123-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "On the Use of a Cluster Identification Method and a Statistical Approach for Analyzing Atom Probe Tomography Data for GP Zones in Al-Zn-Mg(-Cu) Alloys.",
"datePublished": "2023-12-29",
"url": "https://questionsmedicales.fr/article/38156710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/micmic/ozad133"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Systèmes sanguin et immunitaire",
"item": "https://questionsmedicales.fr/mesh/D006424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Leucocytes",
"item": "https://questionsmedicales.fr/mesh/D007962"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agranulocytes",
"item": "https://questionsmedicales.fr/mesh/D007963"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphocytes",
"item": "https://questionsmedicales.fr/mesh/D008214"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lymphocytes T",
"item": "https://questionsmedicales.fr/mesh/D013601"
},
{
"@type": "ListItem",
"position": 8,
"name": "Lymphocytes T CD8+",
"item": "https://questionsmedicales.fr/mesh/D018414"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphocytes T CD8+ - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphocytes T CD8+",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphocytes T CD8+",
"description": "Comment diagnostiquer une déficience en lymphocytes T CD8+ ?\nQuels tests sont utilisés pour évaluer l'activité des lymphocytes T CD8+ ?\nQuels marqueurs sont associés aux lymphocytes T CD8+ ?\nComment évaluer la réponse immunitaire des lymphocytes T CD8+ ?\nQuel rôle joue la cytométrie en flux dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D018414?mesh_terms=Statistical+Distributions&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphocytes T CD8+",
"description": "Quels symptômes indiquent une dysfonction des lymphocytes T CD8+ ?\nComment une carence en lymphocytes T CD8+ se manifeste-t-elle ?\nLes lymphocytes T CD8+ affectent-ils la fatigue ?\nQuels signes cliniques sont associés à une activation des lymphocytes T CD8+ ?\nLes lymphocytes T CD8+ influencent-ils les symptômes allergiques ?",
"url": "https://questionsmedicales.fr/mesh/D018414?mesh_terms=Statistical+Distributions&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphocytes T CD8+",
"description": "Comment renforcer les lymphocytes T CD8+ par l'alimentation ?\nLe vaccin contre la grippe aide-t-il les lymphocytes T CD8+ ?\nQuels modes de vie favorisent la santé des lymphocytes T CD8+ ?\nLes compléments alimentaires sont-ils bénéfiques ?\nComment éviter les infections pour protéger les lymphocytes T CD8+ ?",
"url": "https://questionsmedicales.fr/mesh/D018414?mesh_terms=Statistical+Distributions&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphocytes T CD8+",
"description": "Quels traitements stimulent les lymphocytes T CD8+ ?\nComment les vaccins affectent-ils les lymphocytes T CD8+ ?\nLes traitements antiviraux influencent-ils les lymphocytes T CD8+ ?\nQuel rôle joue la thérapie génique pour les lymphocytes T CD8+ ?\nLes corticostéroïdes affectent-ils les lymphocytes T CD8+ ?",
"url": "https://questionsmedicales.fr/mesh/D018414?mesh_terms=Statistical+Distributions&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphocytes T CD8+",
"description": "Quelles complications peuvent survenir avec une carence en lymphocytes T CD8+ ?\nLes lymphocytes T CD8+ peuvent-ils causer des maladies auto-immunes ?\nComment une réponse immunitaire inappropriée affecte-t-elle la santé ?\nQuelles sont les conséquences d'une immunothérapie sur les lymphocytes T CD8+ ?\nLes lymphocytes T CD8+ sont-ils impliqués dans le rejet de greffe ?",
"url": "https://questionsmedicales.fr/mesh/D018414?mesh_terms=Statistical+Distributions&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphocytes T CD8+",
"description": "Quels facteurs augmentent le risque de carence en lymphocytes T CD8+ ?\nLe stress chronique affecte-t-il les lymphocytes T CD8+ ?\nLes infections virales influencent-elles les lymphocytes T CD8+ ?\nL'alimentation peut-elle affecter les lymphocytes T CD8+ ?\nLes traitements immunosuppresseurs impactent-ils les lymphocytes T CD8+ ?",
"url": "https://questionsmedicales.fr/mesh/D018414?mesh_terms=Statistical+Distributions&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en lymphocytes T CD8+ ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin pour mesurer le nombre de lymphocytes T CD8+ est effectué."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des lymphocytes T CD8+ ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de prolifération cellulaire et des dosages d'interféron gamma sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux lymphocytes T CD8+ ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs CD8 et CD3 sont typiquement utilisés pour identifier ces lymphocytes."
}
},
{
"@type": "Question",
"name": "Comment évaluer la réponse immunitaire des lymphocytes T CD8+ ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut utiliser des tests de cytotoxicité pour mesurer leur capacité à tuer les cellules cibles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la cytométrie en flux dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cytométrie en flux permet de quantifier et de caractériser les lymphocytes T CD8+ dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction des lymphocytes T CD8+ ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une susceptibilité accrue aux infections virales et aux cancers peut indiquer une dysfonction."
}
},
{
"@type": "Question",
"name": "Comment une carence en lymphocytes T CD8+ se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des infections récurrentes et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les lymphocytes T CD8+ affectent-ils la fatigue ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible activité des lymphocytes T CD8+ peut contribuer à une fatigue chronique."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une activation des lymphocytes T CD8+ ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes d'inflammation et des symptômes de réponse immunitaire peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les lymphocytes T CD8+ influencent-ils les symptômes allergiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent moduler la réponse immunitaire, mais ne sont pas directement responsables des allergies."
}
},
{
"@type": "Question",
"name": "Comment renforcer les lymphocytes T CD8+ par l'alimentation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et en vitamines peut soutenir leur fonction."
}
},
{
"@type": "Question",
"name": "Le vaccin contre la grippe aide-t-il les lymphocytes T CD8+ ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il stimule la réponse des lymphocytes T CD8+ contre le virus de la grippe."
}
},
{
"@type": "Question",
"name": "Quels modes de vie favorisent la santé des lymphocytes T CD8+ ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie actif, une bonne hygiène de sommeil et la gestion du stress favorisent leur santé."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires sont-ils bénéfiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments, comme la vitamine D, peuvent soutenir la fonction des lymphocytes T CD8+."
}
},
{
"@type": "Question",
"name": "Comment éviter les infections pour protéger les lymphocytes T CD8+ ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une bonne hygiène, se faire vacciner et éviter les contacts avec des malades aide."
}
},
{
"@type": "Question",
"name": "Quels traitements stimulent les lymphocytes T CD8+ ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunothérapies, comme les inhibiteurs de points de contrôle, stimulent leur activité."
}
},
{
"@type": "Question",
"name": "Comment les vaccins affectent-ils les lymphocytes T CD8+ ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins peuvent induire une réponse des lymphocytes T CD8+ contre des pathogènes spécifiques."
}
},
{
"@type": "Question",
"name": "Les traitements antiviraux influencent-ils les lymphocytes T CD8+ ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements antiviraux peuvent améliorer la fonction des lymphocytes T CD8+."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la thérapie génique pour les lymphocytes T CD8+ ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique peut être utilisée pour modifier les lymphocytes T CD8+ afin de cibler des cancers."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils les lymphocytes T CD8+ ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent inhiber l'activité des lymphocytes T CD8+ et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en lymphocytes T CD8+ ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections graves et des cancers peuvent survenir en raison d'une carence."
}
},
{
"@type": "Question",
"name": "Les lymphocytes T CD8+ peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activation excessive peut contribuer à des maladies auto-immunes par attaque des tissus."
}
},
{
"@type": "Question",
"name": "Comment une réponse immunitaire inappropriée affecte-t-elle la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des inflammations chroniques et des dommages aux tissus sains."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une immunothérapie sur les lymphocytes T CD8+ ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunothérapie peut provoquer des effets secondaires, comme des réactions auto-immunes."
}
},
{
"@type": "Question",
"name": "Les lymphocytes T CD8+ sont-ils impliqués dans le rejet de greffe ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent reconnaître les cellules étrangères et provoquer un rejet de greffe."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en lymphocytes T CD8+ ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, certaines maladies chroniques et l'immunosuppression augmentent ce risque."
}
},
{
"@type": "Question",
"name": "Le stress chronique affecte-t-il les lymphocytes T CD8+ ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer leur nombre et leur efficacité."
}
},
{
"@type": "Question",
"name": "Les infections virales influencent-elles les lymphocytes T CD8+ ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme le VIH, peuvent réduire leur nombre et leur fonction."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle affecter les lymphocytes T CD8+ ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation pauvre en nutriments essentiels peut nuire à leur développement et fonction."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs impactent-ils les lymphocytes T CD8+ ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire le nombre et l'activité des lymphocytes T CD8+ dans l'organisme."
}
}
]
}
]
}
Reduning injection (RDN) is a traditional chinese medicine injection widely used in clinical practice. In this study, qualitative and quantitative analysis of RDN were conducted by UPLC-Orbitrap MS/MS...
Pre-existing particles usually constitute the major fraction of atmospheric particles, except during some episodes in the presence of strong emissions and/or secondary generation of fresh particles. P...
During the poultry sperm cryopreservation process, an excess of reactive oxygen species is generated resulting in oxidative stress which harms the quality of avian spermatozoa. To counteract this effe...
In any single-arm trial on novel treatments, assessment of toxicity plays an important role as occurrence of adverse events (AEs) is relevant for application in clinical practice. In the presence of a...
In the first part of the work we review the strategy of analysis for these two approaches. We identify theoretical quantities and estimators consistent with the following features: (a) estimators shou...
We show through simulations that the proposed methods overcome the bias due to the dependence between the two potential times and related to the use of standard estimators....
We demonstrated through simulations that one can handle patients selection in the risk sets due to the competing event, and thus obtain conditional independence between the two potential times, adjust...
Early-stage clustering in two Al-Mg-Zn(-Cu) alloys has been investigated using atom probe tomography and transmission electron microscopy. Cluster identification by the isoposition method and a statis...
The elderly population is expanding globally. This gives numerous challenges especially regarding hip fracture patients. In the US alone over 300.000 hip fracture patients are treated each year, and a...
This project is an adaptive dose-finding trial. The continuous reassessment method will estimate the maximum tolerable dose of methadone. The primary outcome will be respiratory depression. The statis...
The results of this study will give valuable information about the maximally tolerated dose of methadone for postoperative pain relief for elderly patients with hip fractures and potential adverse eve...
The COVID-19 pandemic disrupted civic life and upended daily routines. Coffee shops, restaurants, recreation centers, parks, and other 'third places' that facilitate communal gathering, interpersonal ...
The supraspinal mechanism plays a key role in developing and maintaining chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). However, it is not clear how white matter changes in young and midd...
Coptidis Rhizoma (CR) is one of the most frequently used herbs to treat ulcerative colitis (UC) and is often processed before usage. However, the composition changes and therapeutic effects of CR befo...
The purpose of the study is to explore the chemical components and therapeutic effects of crude and processed CR....
CR was processed according to the 2020 version of the Chinese Pharmacopoeia. The liquid chromatography-mass spectrometry (LC-MS) and multivariate statistical analysis were used to screen the different...
Ten compounds distinguish crude and processed CR based on multivariate statistical analysis. Network pharmacology predicts that the 10 compounds mainly play a role through TNF-α and IL-6 targets and P...
Overall, CRFE and CRGJ show better effects in treating UC. The chemical changes of processing and the efficacy of processed CR are correlated, which provides a scientific basis for the clinical use of...
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention (CDC) and National Cancer Institute (NCI), is the largest aggregati...
Incidence data were obtained from the CDC's National Program of Cancer Registries (NPCR) and NCI's Surveillance, Epidemiology, and End Results Program for 52 central cancer registries (CCRs). Survival...
The average annual age-adjusted incidence rate of all primary brain and other CNS tumors was 24.25/100 000. Incidence was higher in females and non-Hispanics. The most commonly occurring malignant and...
This summary describes the most up-to-date population-based incidence, mortality, and survival, of primary brain and other CNS tumors in the US and aims to serve as a concise resource for neuro-oncolo...